Oral eplerenone for the management of chronic central serous chorioretinopathy

International Journal of Ophthalmology

Volumn 8, Issue 2, 2015, Pages 310-314

  Singh, Rishi P ^a   Sears, Jonathan E ^a   Bedi, Rumneek ^a   Schachat, Andrew P ^a   Ehlers, Justis P ^a   Kaiser, Peter K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Central serous chorioretinopathy; Central serous retinopathy; Eplerenone; Subretinal fluid

Indexed keywords

EID: 84928599127     PISSN: 22223959     EISSN: 22274898     Source Type: Journal    
DOI: 10.3980/j.issn.2222-3959.2015.02.17     Document Type: Article

References (13)

1. Gruszka A. Potential involvement of mineralcorticoid receptor activation in the pathogenesis of central serous chorioretinopathy: A case report. European Review for Medical and Pharmacological Sciences. 2013;17: 1369-1373
2. Bousquet E, Beydoun T, Zhao M, Hassan L, Offret O, Cohen-Behar F. Mineralcorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: A pilot study. Retina 2013;33(10):2096-2102
3. Bouzas EA, Karadimas P, Pournaras CJ. Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol 2002;47(5):431-448
4. Zhao M, Celerier I, Bousquet E, Jeanny JC, Jonet L, Savoldelli M, Offret O, Curan A, Farman N, Jaisser F, Behar-Cohen F. Mineralcorticoid receptor is involved in rat and human ocular chorioretinopathy. J Clin Invest 2012;122(7):2672-2679
5. Quin G, Liew G, Ho IV, Gillies M, Fraser-Bell S. Diagnosis and interventions for central serous chorioretinopathy: Review and update. Clin Experiment Ophthalmol 2013;41:187-200
6. Gass JDM. Stereoscopic atlas of macular diseases: Diagnosis and treatment. 4th ed. St Louis: Moby Inc. 1997:52-70
7. Guyer DR, Yannuzzi LA, Slakter JS, Sorenson JA, Ho A, Orlock D. Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol 1994;l12(8):1057-1062
8. Hayashi K, Hasegawa Y, Tokoro T. Indocyanine green angiography of central serous chorioretinopathy. Int Ophthalmol 1986;9(1):37-41
9. Piccolino FC, Borgia L. Central serous chorioretinopathy and indocyanine green angiography. Retina 1994;14(3):231-242
10. Delyani JA. Mineralcorticoid receptor antagonists: The evolution of utility and pharmacology. Kidney Int 2000;57(4): 1408-1411
11. Drugs.com [Internet]. Eplerenone Information from Drugs.com; C2000-15. www.drugs.com/mtm/eplerenone.html
12. Lim JI, Glassman AR, Aiello LP, Chakravarthy U, Flaxel CJ, Spaide RF; Macula Society CSC Collaborative Study Group, Research and Education Committee and Website Committee. Collaborative retrospective macula society study of photodynamic therapy for chronic central serous chorioretinopathy. Ophthalomology 2014;121(5):1073-1078
13. Gemenetzi M, De Salvo G, Lotery AJ. Central serous chorioretinopathy: an update on pathogenesis and treatment. Eye (lond) 2010;24 (12): 1743-1756